Ubs Asset Management Americas Inc Illumina, Inc. Transaction History

Ubs Asset Management Americas Inc

$381 Billion
Q3 2024

A detailed history of Ubs Asset Management Americas Inc transactions in Illumina, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 1,260,137 shares of ILMN stock, worth $170 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

1,260,137

Previous 1,205,818 4.5%

Holding current value

$170 Million

Previous $126 Million 30.56%

% of portfolio

0.04%

Previous 0.04%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$105.28 - $135.9 $5.72 Million - $7.38 Million	54,319 Added 4.5%	1,260,137 $164 Million
Q2 2024 Aug 13, 2024	BUY	$101.05 - $133.57 $30.9 Million - $40.9 Million	305,857 Added 33.99%	1,205,818 $126 Million
Q1 2024 May 15, 2024	SELL	$127.73 - $147.2 $1.31 Million - $1.51 Million	-10,292 Reduced 1.13%	899,961 $124 Million
Q4 2023 Feb 14, 2024	SELL	$92.79 - $142.53 $733,504 - $1.13 Million	-7,905 Reduced 0.86%	910,253 $127 Million
Q3 2023 Nov 13, 2023	BUY	$128.91 - $192.44 $10.5 Million - $15.7 Million	81,596 Added 9.75%	918,158 $126 Million
Q1 2023 May 15, 2023	SELL	$193.75 - $232.55 $4.49 Million - $5.38 Million	-23,150 Reduced 2.69%	836,562 $195 Million
Q4 2022 Feb 14, 2023	SELL	$187.24 - $242.74 $12 Million - $15.5 Million	-63,876 Reduced 6.92%	859,712 $174 Million
Q3 2022 Nov 14, 2022	BUY	$177.23 - $227.44 $11.4 Million - $14.6 Million	64,234 Added 7.47%	923,588 $176 Million
Q2 2022 Aug 12, 2022	BUY	$181.58 - $368.0 $10.7 Million - $21.7 Million	59,040 Added 7.38%	859,354 $158 Million
Q1 2022 May 16, 2022	BUY	$303.87 - $423.8 $12 Million - $16.8 Million	39,609 Added 5.21%	800,314 $280 Million
Q4 2021 Feb 14, 2022	BUY	$347.28 - $421.83 $8.71 Million - $10.6 Million	25,079 Added 3.41%	760,705 $289 Million
Q3 2021 Nov 15, 2021	BUY	$405.61 - $524.84 $5.44 Million - $7.04 Million	13,414 Added 1.86%	735,626 $298 Million
Q2 2021 Aug 16, 2021	BUY	$372.84 - $481.5 $68.2 Million - $88.1 Million	182,910 Added 33.92%	722,212 $342 Million
Q1 2021 May 14, 2021	BUY	$361.28 - $504.76 $10 Million - $14 Million	27,794 Added 5.43%	539,302 $207 Million
Q4 2020 Mar 01, 2021	BUY	$292.7 - $370.96 $15.8 Million - $20 Million	53,964 Added 11.79%	511,508 $189 Million
Q3 2020 Nov 13, 2020	SELL	$268.51 - $400.74 $6.23 Million - $9.3 Million	-23,203 Reduced 4.83%	457,544 $141 Million
Q2 2020 Aug 14, 2020	SELL	$256.46 - $373.01 $116,432 - $169,346	-454 Reduced 0.09%	480,747 $178 Million
Q1 2020 May 15, 2020	BUY	$209.2 - $335.53 $6.64 Million - $10.6 Million	31,729 Added 7.06%	481,201 $131 Million
Q4 2019 Feb 14, 2020	BUY	$288.29 - $335.49 $3.92 Million - $4.56 Million	13,589 Added 3.12%	449,472 $149 Million
Q3 2019 Nov 14, 2019	BUY	$266.84 - $378.23 $1.07 Million - $1.52 Million	4,007 Added 0.93%	435,883 $133 Million
Q2 2019 Aug 15, 2019	SELL	$300.59 - $368.15 $260,010 - $318,449	-865 Reduced 0.2%	431,876 $0
Q1 2019 May 14, 2019	SELL	$272.57 - $321.18 $1.02 Million - $1.2 Million	-3,725 Reduced 0.85%	432,741 $0
Q4 2018 Feb 13, 2019	BUY	$272.46 - $366.54 $2.22 Million - $2.99 Million	8,166 Added 1.91%	436,466 $131 Million
Q3 2018 Nov 14, 2018	BUY	$279.04 - $367.06 $189,468 - $249,233	679 Added 0.16%	428,300 $0
Q2 2018 Aug 14, 2018	SELL	$228.17 - $292.07 $1.5 Million - $1.92 Million	-6,573 Reduced 1.51%	427,621 $0
Q1 2018 May 14, 2018	BUY	$209.54 - $253.91 $11.4 Million - $13.8 Million	54,512 Added 14.36%	434,194 $0
Q4 2017 Feb 09, 2018	BUY	$202.23 - $230.03 $462,904 - $526,538	2,289 Added 0.61%	379,682 $0
Q3 2017 Nov 13, 2017	BUY	$172.3 - $213.93 $65 Million - $80.7 Million	377,393	377,393 $0

Others Institutions Holding ILMN

# of Institutions

900

Shares Held

137M

Call Options Held

1.22M

Put Options Held

1.43M

View Full List

About ILLUMINA, INC.

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $21.2B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

More about ILMN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Account

Ubs Asset Management Americas Inc Illumina, Inc. Transaction History